EVGN (Evogene) Float Percentage Of Total Shares Outstanding: 99.32% (As of Jul. 06, 2026)


EVGN Evogene Ltd EVGN
33 GF Score
Price $0.44
GF Value $0.40
Valuation Fairly Valued
! 7 Warning Signs
View Full Analysis

What is Evogene Float Percentage Of Total Shares Outstanding?

Evogene EVGN -2.56% 33 Float Percentage Of Total Shares Outstanding is 99.32% as of Jul. 06, 2026. GuruFocus rates EVGN with a GF Score™ of 33/100 and a GF Value™ of $0.40 (Fairly Valued). The stock has 7 warning signs investors should review.

Float percentage of total shares outstanding is the percentage of float shares relative to the total shares outstanding. As of today, Evogene's float shares is 12.02 Mil. Evogene's total shares outstanding is 12.10 Mil. Evogene's float percentage of total shares outstanding is 99.32%.

Insider Ownership is the percentage of shares that are owned by company insiders relative to the total shares outstanding. As of today, Evogene's Insider Ownership is 0.96%.

Institutional Ownership is the percentage of shares that are owned by institutions out of the total shares outstanding. As of today, Evogene's Institutional Ownership is 4.38%.

EVGN
33GF Score
Evogene Ltd EVGN
Float Percentage Of Total Shares Outstanding is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Evogene Float Percentage Of Total Shares Outstanding Calculation

It is the percentage of float shares out of the total shares outstanding.

Evogene's Float Percentage of Total Shares Outstanding for today is calculated as follows:

Float Percentage of Total Shares Outstanding=Float Shares/Total Shares Outstanding
=12.02/12.10
=99.32%

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

What does a Float Percentage Of Total Shares Outstanding of 99.32% mean?
Evogene (EVGN) has a Float Percentage Of Total Shares Outstanding of 99.32% as of Jul. 06, 2026. Float percent of shares outstanding equals the percent of float shares relative to total shares. View historical data on Evogene and its competitors.
Is Evogene's Float Percentage Of Total Shares Outstanding too high?
Evogene's current Float Percentage Of Total Shares Outstanding is 99.32%. Overall, Evogene has a GF Score™ of 33/100 and is considered Fairly Valued, reflecting its overall financial health beyond just this single metric.
How does Evogene's Float Percentage Of Total Shares Outstanding compare to VRTX and REGN?
Evogene's Float Percentage Of Total Shares Outstanding of 99.32% can be compared against companies in the Biotechnology industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Float Percentage Of Total Shares Outstanding for a Biotechnology company?
A good Float Percentage Of Total Shares Outstanding depends on the Biotechnology industry context. However, Float Percentage Of Total Shares Outstanding should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Float Percentage Of Total Shares Outstanding mean?
A high Float Percentage Of Total Shares Outstanding can signal that a stock is expensive relative to its fundamentals. Float percent of shares outstanding equals the percent of float shares relative to total shares. View historical data on Evogene and its competitors. Evogene's current Float Percentage Of Total Shares Outstanding is 99.32%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Evogene stock overvalued right now?
Based on GuruFocus' analysis, Evogene (EVGN) is currently considered Fairly Valued. The stock's GF Value™ is $0.40, compared to a current price of $0.44 — trading 9.5% above its estimated fair value. The current Float Percentage Of Total Shares Outstanding is 99.32%. Evogene's overall GF Score™ is 33/100 with 7 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Float Percentage Of Total Shares Outstanding calculated?
Float Percentage Of Total Shares Outstanding is calculated from a company's financial statements. For Evogene (EVGN), the current Float Percentage Of Total Shares Outstanding is 99.32% as of Jul. 06, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Evogene (EVGN) Overvalued in 2026?

Based on GuruFocus' analysis, Evogene stock appears to be overvalued. The current stock price of $0.44 is trading 9.5% above its estimated GF Value™ of $0.40. GuruFocus considers Evogene to be Fairly Valued.

Key valuation signals for EVGN:

  • Float Percentage Of Total Shares Outstanding: 99.32%
  • GF Value™: $0.40 vs. price of $0.44 (9.5% above fair value)
  • GF Score™: 33/100 with 7 warning signs

No single metric tells the full story. See the EVGN stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Evogene Business Description

Other Exchanges EVGN:Israel
Address 13 Gad Feinstein Street, Park Rehovot, Ness Ziona, Rehovot, ISR, 7638517
Evogene Ltd is a computational biology company targeting to revolutionize product development for life-science based industries, including human health, agriculture, and industrial applications. The company established its technology, the Computational Predictive Biology (CPB) platform. The CPB platform is designed to computationally discover and develop life-science products based on microbes, small molecules, and genetic elements as the core components for such products. It holds several subsidiaries utilizing the CPB platform for the development of human microbiome-based therapeutics, medical cannabis, ag-biologicals, ag-chemicals, seed traits, and ag-solutions for castor oil production. It generates maximum revenue from the industrial segment, followed by Agriculture.
33GF Score

Get the complete analysis for EVGN

Float Percentage Of Total Shares Outstanding is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$0.44
Price
$0.40
GF Value